Using an approach based on FBA and the metabolic knowledge acquired during model construction, a medium was designed that increased the production of PT (the limiting antigen in acellular pertussis vaccine manufacturing [32]) by 2.4-fold. The gene discussed is F2; the disease is pertussis.